Marimed (MRMD) Net Cash Flow (2012 - 2026)

Marimed (MRMD) has 15 years of Net Cash Flow data on file, last reported at -$947000.0 in Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$947000.0, down 1069.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $736000.0 (up 109.16% YoY), and the FY2025 annual result was $1.6 million, up 121.76% from the prior year.
• Net Cash Flow slipped to -$947000.0 in Q1 2026 per MRMD's latest filing, from $2.3 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $11.9 million in Q1 2023 and troughed at -$25.6 million in Q2 2022.
• A 5-year average of -$1.3 million and a median of -$404000.0 in 2024 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2023 and 2026: Net Cash Flow soared 213.37% in 2023, then plunged 1069.14% in 2026.
• A 5-year view of Net Cash Flow shows it stood at -$1.4 million in 2022, then soared by 200.73% to $1.4 million in 2023, then plunged by 280.81% to -$2.5 million in 2024, then soared by 191.3% to $2.3 million in 2025, then tumbled by 141.39% to -$947000.0 in 2026.
• Business Quant data shows MRMD's Net Cash Flow at -$947000.0 in Q1 2026, $2.3 million in Q4 2025, and $458000.0 in Q3 2025.